Nature of Operations and Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended		9 Months Ended				9 Months Ended		1 Months Ended		0 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011	Dec. 31, 2010	Sep. 30, 2012 Common Stock [Member]	Feb. 29, 2012 Common Stock [Member]	Feb. 29, 2012 Warrant [Member]	Sep. 30, 2012 Warrant [Member]	Dec. 27, 2011 Line of Credit [Member]
Securities Financing Transaction [Line Items]
Cash and cash equivalents	$ 1,456,000	$ 2,858,000	$ 1,456,000	$ 2,858,000	$ 1,709,000	$ 5,448,000
Working capital	4,500,000		4,500,000
Net cash used in operations			(3,128,000)	(3,948,000)
Net loss	(324,000)	(1,684,000)	(2,455,000)	(5,174,000)
Line of credit, maximum aggregrate borrowing amount											2,000,000
Percentage of eligible accounts receivable, which advance requests may be made against											75.00%
Variable rate basis											prime rate
Basis spread on variable rate											2.00%
Interest rate minimum, per annum											5.25%
Minimum facility payment, per month											5,000
Line of credit, available borrowing capacity	856,000		856,000
Shares of common stock and warrants							6,415,000
Number of shares authorized in registered offering									3,207,500
Number of shares called by warrant units								1	0.5
Warrants, price per unit (in dollars per share)									$ 0.50
Proceeds from sale of common stock and warrants									3,207,500
Proceeds from sale of common stock and warrants, net									$ 2,800,000
Exercisable warrants										0